摘要
Summary The Laser intervention in early stages of age-related macular degeneration(LEAD)study(1)is a 36-month,multicenter,randomized,sham-controlled trial conducted from 2012-2015 of 292 participants with bilateral soft drusen,aka intermediate AMD(iAMD),who underwent q 6-month treatment with sub-threshold nanosecond laser(SNL)or sham treatment to the study eye.
基金
This work was supported in part by NIH/NEI R01EY015520.
